Sir Philip Cohen has served as a Faculty member at the University of Dundee since 1971 where his research has been devoted to studying the role of protein phosphorylation in cell regulation and human disease. Sir Philip was elected a Fellow of both The Royal Society of London and The Royal Society of Edinburgh in 1984, was knighted by the Queen in 1998 and has received honorary doctorates from five Universities. Philip is also the Director of the recently announced £10million Scottish Institute of Cell Signaling, Director of the Medical Research Council Protein Phosphorylation Unit and Co-Director of the Division of Signal Transduction Therapy (DSTT) the UK’s largest collaboration between a basic research institution and the pharmaceutical industry. It is widely regarded as a model for how industry and academia should interact, for which it received a Queen’s Anniversary Award for Higher Education in 2006. In 2008, he was elected a member of the National Academy of Sciences (NAS) for his excellence in original scientific research. Philip Cohen received his B.Sc. and Ph.D. from University College London, England.